{"rows":[{"id":5984,"title":"Psychedelics restructure information in the human brain","authors":"Blackburne, G.; Liardi, A.; Mallaroni, P.; McAlpine, R.; Carhart-Harris, R.; Timmermann, C.; Muthukumaraswamy, S. D.; Skipper, J. I.; Mediano, P. A. M.","journal":"bioRxiv","publication_date":"2026-10-08","publication_year":2026,"doi":"10.64898/2026.10.01.755915","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.10.01.755915","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"bioRxiv","publication_status":"preprint","date_added":"2026-10-09 01:23:29","last_checked":"2026-10-09 01:23:29","bibtex":null,"source_record_id":"DOI:10.64898/2026.10.01.755915","abstract_available":true,"abstract_source":"bioRxiv","abstract_source_url":"https://doi.org/10.64898/2026.10.01.755915","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"bioRxiv","source_record_id":"DOI:10.64898/2026.10.01.755915","source_url":"https://doi.org/10.64898/2026.10.01.755915","doi":"10.64898/2026.10.01.755915","pmid":"","publication_date":"2026-10-08","importer_version":"2.1.3","text_redistributed":false}},{"id":5983,"title":"Preparing the body for psilocybin therapy: receptive and generative interoception in cancer patients","authors":"Back Anthony L., Price Cynthia J., McGregor Bonnie A., Markell Andrew","journal":"Frontiers in Psychiatry","publication_date":"2026-10-08","publication_year":2026,"doi":"10.3389/fpsyt.2026.1890966","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.3389/fpsyt.2026.1890966","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Emotional Processing,Clinical Trial,Cancer Patients","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-10-09 01:20:15","last_checked":"2026-10-09 01:20:15","bibtex":null,"source_record_id":"DOI:10.3389/fpsyt.2026.1890966","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3389/fpsyt.2026.1890966","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3389/fpsyt.2026.1890966","source_url":"https://doi.org/10.3389/fpsyt.2026.1890966","doi":"10.3389/fpsyt.2026.1890966","pmid":"","publication_date":"2026-10-08","importer_version":"2.1.3","text_redistributed":false}},{"id":5982,"title":"From regulation to practice: A scoping review of prescribers’ roles in psilocybin-assisted therapy","authors":"Bélanger Gabriel, Chang Sue-Ling, Masse-Grenier Marianne, Tremblay Marie-Joëlle, Farzin Houman, Garel Nicolas, Dorval Michel","journal":"Drug Science, Policy and Law","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1177/20503245261494890","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.1177/20503245261494890","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Review Article,Safety","study_type":"Review Article","source_name":"Crossref","publication_status":"published","date_added":"2026-10-08 01:20:19","last_checked":"2026-10-08 01:20:19","bibtex":null,"source_record_id":"DOI:10.1177/20503245261494890","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1177/20503245261494890","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1177/20503245261494890","source_url":"https://doi.org/10.1177/20503245261494890","doi":"10.1177/20503245261494890","pmid":"","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5981,"title":"Psilocybin-Assisted Therapy in Depressive Disorders: Clinical Governance, Safety, and Translational Challenges","authors":"Szilvia Salima Bartha Msc In Business Administration","journal":null,"publication_date":"2026-10-05","publication_year":2026,"doi":"10.13140/rg.2.2.17829.05608","pubmed_id":null,"openalex_id":"https://openalex.org/W7220414206","source_url":"https://doi.org/10.13140/rg.2.2.17829.05608","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-07 01:20:24","last_checked":"2026-10-09 01:20:19","bibtex":null,"source_record_id":"DOI:10.13140/rg.2.2.17829.05608","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.13140/rg.2.2.17829.05608","source_url":"https://doi.org/10.13140/rg.2.2.17829.05608","doi":"10.13140/rg.2.2.17829.05608","pmid":"","publication_date":"2026-10-05","importer_version":"2.1.3","text_redistributed":false}},{"id":5980,"title":"Caution before canonisation: a clinical and implementation science perspective on psychedelics","authors":"Andreas Paris, Foteïni Thoma, Aikaterini Velentza, Panagiota Pavlopoulou, Giorgos Metaxas","journal":"Frontiers in Psychiatry","publication_date":"2026-10-05","publication_year":2026,"doi":"10.3389/fpsyt.2026.1922928","pubmed_id":null,"openalex_id":"https://openalex.org/W7220367324","source_url":"https://doi.org/10.3389/fpsyt.2026.1922928","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Addiction,Spirituality,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-07 01:20:24","last_checked":"2026-10-09 01:20:19","bibtex":null,"source_record_id":"DOI:10.3389/fpsyt.2026.1922928","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.3389/fpsyt.2026.1922928","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.3389/fpsyt.2026.1922928","source_url":"https://doi.org/10.3389/fpsyt.2026.1922928","doi":"10.3389/fpsyt.2026.1922928","pmid":"","publication_date":"2026-10-05","importer_version":"2.1.3","text_redistributed":false}},{"id":5979,"title":"Psilocybin use, mental health treatment utilization, and unmet treatment need among US individuals with depression.","authors":"Eun AC, Yang KH, Palamar JJ","journal":"Psychological medicine","publication_date":"2026-10-06","publication_year":2026,"doi":"10.1017/s0033291726106163","pubmed_id":"42834832","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42834832/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-10-07 01:20:05","last_checked":"2026-10-09 01:20:05","bibtex":null,"source_record_id":"PMID:42834832","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42834832/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42834832","source_url":"https://pubmed.ncbi.nlm.nih.gov/42834832/","doi":"10.1017/s0033291726106163","pmid":"42834832","publication_date":"2026-10-06","importer_version":"2.1.3","text_redistributed":false}},{"id":5978,"title":"Psychedelics Restructure the Global Workspace of Consciousness","authors":"Yousefi, P.; Shinozuka, K.; Vizeli, P.; Holze, F.; Becker, A. M.; Muller, F.; Liechti, M. E.; Hasler, G.; Rodriguez, C. I.; Luppi, A.; Mediano, P. A. M.","journal":"bioRxiv","publication_date":"2026-10-05","publication_year":2026,"doi":"10.64898/2026.09.28.755172","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.09.28.755172","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Mechanism of Action,Consciousness,Aging,Drug Interactions","study_type":"Other","source_name":"bioRxiv","publication_status":"preprint","date_added":"2026-10-06 01:20:25","last_checked":"2026-10-09 01:23:29","bibtex":null,"source_record_id":"DOI:10.64898/2026.09.28.755172","abstract_available":true,"abstract_source":"bioRxiv","abstract_source_url":"https://doi.org/10.64898/2026.09.28.755172","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"bioRxiv","source_record_id":"DOI:10.64898/2026.09.28.755172","source_url":"https://doi.org/10.64898/2026.09.28.755172","doi":"10.64898/2026.09.28.755172","pmid":"","publication_date":"2026-10-05","importer_version":"2.1.3","text_redistributed":false}},{"id":5977,"title":"Therapists’ Perspectives on the Psychotherapeutic Support in Psilocybin Treatment for Major Depressive Disorder: Insights from a Randomized Controlled Trial","authors":"Kjellgren A, Lundberg J, Yngwe H, Ekman CJ, Tiger M, Ljunglöf T, Stridh F, Beckman M.","journal":"Research Square","publication_date":"2026-10-05","publication_year":2026,"doi":"10.21203/rs.3.rs-10879308/v1","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10879308/v1","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"Europe PMC","publication_status":"preprint","date_added":"2026-10-06 01:20:24","last_checked":"2026-10-09 01:20:16","bibtex":null,"source_record_id":"DOI:10.21203/rs.3.rs-10879308/v1","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.21203/rs.3.rs-10879308/v1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-10879308/v1","source_url":"https://doi.org/10.21203/rs.3.rs-10879308/v1","doi":"10.21203/rs.3.rs-10879308/v1","pmid":"","publication_date":"2026-10-05","importer_version":"2.1.3","text_redistributed":false}},{"id":5976,"title":"An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder.","authors":"Tiwari, P.; Nayak, S. M.; Sepeda, N. D.; Ehrenkranz, R.; Levine, M. A.; Rohde, J. S.; Miller, E.; Beritela, C. M.; Scott, J. V.; Nestadt, G.; Barrett, F. S.; Yaden, D. B.","journal":"medRxiv","publication_date":"2026-10-05","publication_year":2026,"doi":"10.64898/2026.10.01.26364511","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.10.01.26364511","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,OCD,Consciousness,Mystical Experience,Clinical Trial,Healthcare Workers,Safety","study_type":"Clinical Trial","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-10-06 01:20:24","last_checked":"2026-10-09 01:20:46","bibtex":null,"source_record_id":"DOI:10.64898/2026.10.01.26364511","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.10.01.26364511","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.10.01.26364511","source_url":"https://doi.org/10.64898/2026.10.01.26364511","doi":"10.64898/2026.10.01.26364511","pmid":"","publication_date":"2026-10-05","importer_version":"2.1.3","text_redistributed":false}},{"id":5975,"title":"Study participant perceptions of the relevance of therapist and study team personal psychedelic experience","authors":"Benjamin R. Lewis, Eric L. Garland, Zach Schwartz, Yitong Xin, Kevin Byrne, Kious Brent","journal":"Psychedelics","publication_date":"2026-10-03","publication_year":2026,"doi":"10.1016/j.psyche.2026.100041","pubmed_id":null,"openalex_id":"https://openalex.org/W7218519509","source_url":"https://doi.org/10.1016/j.psyche.2026.100041","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Spirituality,Randomized Controlled Trial,Healthcare Workers","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-10-05 01:20:20","last_checked":"2026-10-09 01:20:19","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100041","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100041","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.psyche.2026.100041","source_url":"https://doi.org/10.1016/j.psyche.2026.100041","doi":"10.1016/j.psyche.2026.100041","pmid":"","publication_date":"2026-10-03","importer_version":"2.1.3","text_redistributed":false}},{"id":5974,"title":"Psychedelics and disorders of consciousness: a new frontier in neurotherapeutics.","authors":"Du X, Peng F, Wang X.","journal":"Molecular psychiatry","publication_date":"2026-10-03","publication_year":2026,"doi":"10.1038/s41380-026-03918-4","pubmed_id":"42829371","openalex_id":null,"source_url":"https://doi.org/10.1038/s41380-026-03918-4","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Review Article,Safety","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-05 01:20:04","last_checked":"2026-10-09 01:20:16","bibtex":null,"source_record_id":"PMID:42829371","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1038/s41380-026-03918-4","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42829371","source_url":"https://doi.org/10.1038/s41380-026-03918-4","doi":"10.1038/s41380-026-03918-4","pmid":"42829371","publication_date":"2026-10-03","importer_version":"2.1.3","text_redistributed":false}},{"id":5973,"title":"Serotonergic Toxicity and Hyponatremia Associated with Antidepressant Therapy: The Pivotal Role of SIADH.","authors":"Morena D, Lippi M, Biso L, Lucci F, Turillazzi E, Fineschi V, Scognamiglio P.","journal":"Clinical drug investigation","publication_date":"2026-10-03","publication_year":2026,"doi":"10.1007/s40261-026-01599-z","pubmed_id":"42829418","openalex_id":"https://openalex.org/W7218417106","source_url":"https://doi.org/10.1007/s40261-026-01599-z","substance_tags":"psilocybin","topic_tags":"Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Case Report,Safety,Toxicity,Drug Interactions","study_type":"Review Article","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-05 01:20:04","last_checked":"2026-10-09 01:20:19","bibtex":null,"source_record_id":"PMID:42829418","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1007/s40261-026-01599-z","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42829418","source_url":"https://doi.org/10.1007/s40261-026-01599-z","doi":"10.1007/s40261-026-01599-z","pmid":"42829418","publication_date":"2026-10-03","importer_version":"2.1.3","text_redistributed":false}},{"id":5972,"title":"Through the PRISM: Reinterpreting Psychedelic Cognition as Motivational Reallocation","authors":"Ceyda Sayali","journal":"PsyArXiv","publication_date":"2026-10-02","publication_year":2026,"doi":"10.31234/osf.io/dgns5_v2","pubmed_id":null,"openalex_id":null,"source_url":"https://osf.io/preprints/psyarxiv/dgns5_v2","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Default Mode Network,Aging,Emotional Processing","study_type":"Other","source_name":"PsyArXiv","publication_status":"preprint","date_added":"2026-10-03 01:24:34","last_checked":"2026-10-09 01:24:39","bibtex":null,"source_record_id":"DOI:10.31234/osf.io/dgns5_v2","abstract_available":true,"abstract_source":"PsyArXiv","abstract_source_url":"https://osf.io/preprints/psyarxiv/dgns5_v2","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PsyArXiv","source_record_id":"DOI:10.31234/osf.io/dgns5_v2","source_url":"https://osf.io/preprints/psyarxiv/dgns5_v2","doi":"10.31234/osf.io/dgns5_v2","pmid":"","publication_date":"2026-10-02","importer_version":"2.1.3","text_redistributed":false}},{"id":5971,"title":"Placebo, Psilocybin und der vermaledeite p-Wert","authors":"","journal":"Nervenheilkunde","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1055/a-2911-3837","pubmed_id":null,"openalex_id":"https://openalex.org/W7216556715","source_url":"https://doi.org/10.1055/a-2911-3837","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-10-03 01:20:22","last_checked":"2026-10-08 01:20:23","bibtex":null,"source_record_id":"DOI:10.1055/a-2911-3837","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1055/a-2911-3837","source_url":"https://doi.org/10.1055/a-2911-3837","doi":"10.1055/a-2911-3837","pmid":"","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5970,"title":"U.S. Veterans and Psychedelics: Prevalence of Use and Policy Preferences.","authors":"Priest M, Schell TL, Senator B, Kilmer B.","journal":"Rand health quarterly","publication_date":"2026-09-29","publication_year":2026,"doi":"10.7249/rhq-13-04-08","pubmed_id":"42824827","openalex_id":null,"source_url":"https://doi.org/10.7249/rhq-13-04-08","substance_tags":"psilocybin","topic_tags":"PTSD,Observational Study,Veterans","study_type":"Observational Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-03 01:20:07","last_checked":"2026-10-06 01:20:25","bibtex":null,"source_record_id":"PMID:42824827","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.7249/rhq-13-04-08","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42824827","source_url":"https://doi.org/10.7249/rhq-13-04-08","doi":"10.7249/rhq-13-04-08","pmid":"42824827","publication_date":"2026-09-29","importer_version":"2.1.3","text_redistributed":false}},{"id":5969,"title":"Open-label, Single-arm fMRI Study Evaluating the Effects of Psilocybin on Craving in Nicotine Dependence.","authors":"University of British Columbia","journal":"ClinicalTrials.gov","publication_date":"2026-10-01","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07852832","substance_tags":"psilocybin","topic_tags":"Addiction,Brain Imaging,Aging","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-10-02 01:26:31","last_checked":"2026-10-08 01:24:59","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07852832","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07852832","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07852832","source_url":"https://clinicaltrials.gov/study/NCT07852832","doi":"","pmid":"","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5968,"title":"Embeddedness under psilocybin.","authors":"Howells H.","journal":"Nature neuroscience","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1038/s41593-026-02476-w","pubmed_id":"42823471","openalex_id":"https://openalex.org/W7215056171","source_url":"https://doi.org/10.1038/s41593-026-02476-w","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-10-02 01:20:19","last_checked":"2026-10-08 01:20:23","bibtex":null,"source_record_id":"PMID:42823471","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42823471","source_url":"https://doi.org/10.1038/s41593-026-02476-w","doi":"10.1038/s41593-026-02476-w","pmid":"42823471","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5967,"title":"The New Mexico Medical Psilocybin Act and current trends in the United States psychedelic policy","authors":"Borbón Diego","journal":"Psychedelics","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100043","pubmed_id":null,"openalex_id":"https://openalex.org/W7215079204","source_url":"https://doi.org/10.1016/j.psyche.2026.100043","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-10-02 01:20:19","last_checked":"2026-10-08 01:20:23","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100043","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100043","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100043","source_url":"https://doi.org/10.1016/j.psyche.2026.100043","doi":"10.1016/j.psyche.2026.100043","pmid":"","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5966,"title":"F25. COMPARING PSILOCYBIN-ASSISTED THERAPY AND SSRIS IN THE TREATMENT OF LATE-LIFE DEPRESSION","authors":"Lall Talia, Lin Anabel, Espinosa Juan","journal":"The American Journal of Geriatric Psychiatry","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1016/j.jagp.2026.03.128","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.1016/j.jagp.2026.03.128","substance_tags":"psilocybin","topic_tags":"Depression","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-10-01 01:20:24","last_checked":"2026-10-08 01:20:19","bibtex":null,"source_record_id":"DOI:10.1016/j.jagp.2026.03.128","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.jagp.2026.03.128","source_url":"https://doi.org/10.1016/j.jagp.2026.03.128","doi":"10.1016/j.jagp.2026.03.128","pmid":"","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5965,"title":"Stroboscopic light stimulation as a controllable probe of the psilocybin state: a mechanistic framework and a falsifiable prediction","authors":"Żełabowski Kacper, Wieczorek Tomasz, Hamed Adam","journal":"Frontiers in Pharmacology","publication_date":"2026-09-30","publication_year":2026,"doi":"10.3389/fphar.2026.1852799","pubmed_id":null,"openalex_id":"https://openalex.org/W7214906093","source_url":"https://doi.org/10.3389/fphar.2026.1852799","substance_tags":"psilocybin,psilocin","topic_tags":"Brain Imaging,Receptor Pharmacology,Consciousness,Aging,Drug Interactions","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-10-01 01:20:23","last_checked":"2026-10-07 01:20:24","bibtex":null,"source_record_id":"DOI:10.3389/fphar.2026.1852799","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3389/fphar.2026.1852799","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3389/fphar.2026.1852799","source_url":"https://doi.org/10.3389/fphar.2026.1852799","doi":"10.3389/fphar.2026.1852799","pmid":"","publication_date":"2026-09-30","importer_version":"2.1.3","text_redistributed":false}}],"total":5079,"page":1,"per_page":20,"pages":254,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}